Catcheside Peter G
F1000 Med Rep. 2010 Sep 23;2:70. doi: 10.3410/M2-70.
Continuous positive airway pressure (CPAP) is the leading treatment for obstructive sleep apnoea (OSA), a prevalent disorder of breathing in sleep strongly associated with obesity. OSA has serious adverse health, social and community effects arising from disturbed breathing, loud snoring, poor quality sleep and cardiovascular sequelae. When used appropriately, CPAP treatment is highly effective in normalising breathing and sleep, improving symptoms and lowering adverse event risk. However, patients do not necessarily accept, tolerate or comply with treatment, with many factors influencing CPAP uptake and longer term use. Although knowledge to address challenges affecting CPAP adherence and CPAP mask and machine technologies continue to improve incrementally, optimising CPAP treatment adherence is an ongoing challenge in sleep medicine.
持续气道正压通气（CPAP）是阻塞性睡眠呼吸暂停（OSA）的主要治疗方法，OSA是一种常见的睡眠呼吸障碍，与肥胖密切相关。OSA会因呼吸紊乱、大声打鼾、睡眠质量差和心血管后遗症而产生严重的健康、社会和社区不良影响。当正确使用时，CPAP治疗在使呼吸和睡眠正常化、改善症状以及降低不良事件风险方面非常有效。然而，患者不一定会接受、耐受或依从治疗，有许多因素会影响CPAP的采用和长期使用。尽管应对影响CPAP依从性的挑战的知识以及CPAP面罩和机器技术在不断逐步改进，但优化CPAP治疗依从性仍是睡眠医学中一项持续存在的挑战。
